slotkoers
Korea S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.765
KRW
|
+5,53%
|
|
+5,74%
|
-23,30%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
228.585
|
144.347
|
74.289
|
61.214
|
Bedrijfswaarde
1 |
193.838
|
120.245
|
45.823
|
45.710
|
K/w-verhouding
|
-26,4
x
|
-18,8
x
|
-10,4
x
|
-4,5
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1.000
x
|
536
x
|
207
x
|
252
x
|
Bedrijfswaarde/omzet
|
848
x
|
447
x
|
128
x
|
188
x
|
Bedrijfswaarde/EBITDA
|
-54,2
x
|
-33,1
x
|
-5,86
x
|
-3,92
x
|
Bedrijfswaarde/FCF
|
-78,1
x
|
-12,6
x
|
-9,06
x
|
-18,6
x
|
FCF Yield
|
-1,28%
|
-7,91%
|
-11%
|
-5,37%
|
Price to Book
|
6,54
x
|
4,62
x
|
2,56
x
|
4,08
x
|
Aantal aandelen (in duizenden)
|
16.932
|
16.932
|
16.980
|
16.980
|
Referentieprijs
2 |
13.500
|
8.525
|
4.375
|
3.605
|
Datum van publicatie
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
276,5
|
407,6
|
228,5
|
269,3
|
358,3
|
243,2
|
EBITDA
1 |
-3.180
|
-3.010
|
-3.575
|
-3.628
|
-7.821
|
-11.654
|
Bedrijfsresultaat (EBIT)
1 |
-3.376
|
-3.292
|
-3.923
|
-4.067
|
-8.320
|
-12.207
|
Operationele Marge
|
-1.220,85%
|
-807,56%
|
-1.716,79%
|
-1.510,39%
|
-2.322,35%
|
-5.019,47%
|
Resultaat voor belastingen (EBT)
1 |
-7.345
|
-3.853
|
-3.843
|
-3.831
|
-8.301
|
-13.602
|
Nettowinst (verlies)
1 |
-7.345
|
-3.853
|
-3.843
|
-3.831
|
-7.116
|
-13.602
|
Nettomarge
|
-2.656,33%
|
-945,2%
|
-1.681,97%
|
-1.422,73%
|
-1.986,19%
|
-5.593,04%
|
WPA
2 |
-4.039
|
-764,0
|
-511,2
|
-452,5
|
-419,4
|
-801,0
|
Free Cash Flow
1 |
10.982
|
-15.435
|
-2.482
|
-9.515
|
-5.055
|
-2.455
|
FCF-marge
|
3.971,77%
|
-3.786,79%
|
-1.086,23%
|
-3.533,66%
|
-1.411,03%
|
-1.009,64%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
4.672
|
7.280
|
34.747
|
24.103
|
28.466
|
15.504
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
10.982
|
-15.435
|
-2.482
|
-9.515
|
-5.055
|
-2.455
|
ROE (netto-inkomsten/eigen vermogen)
|
50,9%
|
111%
|
-18,2%
|
-11,5%
|
-23,5%
|
-60,9%
|
ROA (netto-inkomsten/totale activa)
|
-29,3%
|
-21,3%
|
-10,8%
|
-7,24%
|
-13,2%
|
-19,5%
|
Totale activa
1 |
25.030
|
18.081
|
35.469
|
52.897
|
53.988
|
69.692
|
Nettoactief per aandeel
2 |
-10.106
|
1.331
|
2.064
|
1.844
|
1.707
|
884,0
|
Cashflow per aandeel
2 |
5.394
|
1.422
|
275,0
|
59,60
|
72,00
|
72,90
|
Capex
1 |
324
|
186
|
349
|
7.081
|
309
|
297
|
Capex/omzet
|
117,04%
|
45,63%
|
152,89%
|
2.629,62%
|
86,22%
|
122,19%
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -23,30% | 34,07 mln. | | +19,41% | 45,51 mld. | | +38,65% | 38,13 mld. | | -8,62% | 38,52 mld. | | +26,95% | 30,74 mld. | | -13,50% | 26,03 mld. | | +10,74% | 25,92 mld. | | +44,87% | 14,13 mld. | | +34,36% | 12,73 mld. | | -7,14% | 11,29 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|